Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials

Published:2011-01-08 Issue:7 Volume:100 Page:561-570
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

de Waha Antoinette,Dibra Alban,Kufner Sebastian,Baumgart Dietrich,Sabate Manel,Maresta Aleardo,Schömig Albert,Kastrati Adnan

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-010-0278-8.pdf

Reference36 articles.

1. Hammoud T, Tanguay JF, Bourassa MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36(2):355–365

2. Berry C, Tardif JC, Bourassa MG (2007) Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization. J Am Coll Cardiol 49(6):643–656

3. Abizaid A, Kornowski R, Mintz GS et al (1998) The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32(3):584–589

4. Elezi S, Kastrati A, Pache J et al (1998) Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32(7):1866–1873

5. Weber FD, Schneider H, Wiemer M et al (2008) Sirolimus eluting stent (Cypher™) in patients with diabetes mellitus: results from the German Cypher Stent Registry. Clin Res Cardiol 97(2):105–109

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Diabetes on 10‐Year Outcomes Following ST‐Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION‐EXTEND Trial;Journal of the American Heart Association;2022-12-06

2. Percutaneous Coronary Intervention in Diabetic Patients;Interventional Treatment for Structural Heart Disease;2021-11-24

3. Chronic low-dose rapamycin treatment fine tunes cardioprotective signalling in ischaemia-reperfused diabetic hearts;Cardiovascular Research;2020-10-20

4. STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice;Cardiovascular Research;2019-11-18

5. Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes;Oxidative Medicine and Cellular Longevity;2017